Market Research Report

A quick peek into the report

Global Long-Read Sequencing Market

Focus on Products and Services, Technology, Application, End User, Country Data (17 Countries), and Competitive Landscape - Analysis and Forecast, 2021-2030

Some Faq's

Frequently Asked Questions

The long-read sequencing market is expected to grow at a CAGR of 21.15% during the forecast period from 2021-2030.

Some of the opportunities that have the potential to open the unexplored areas, including massive scope for adoption of genomic data analysis software in emerging nations and novel diagnostic applications.

Factors driving the growth market include decreasing cost of sequencing, global increase in cancer prevalence, and increasing number of population genomics initiatives.

Areas of applications where long-read sequencing can be used include oncology, infectious diseases, rare diseases, genetic disorders, metabolic disorders, and translational research.

Some of the players operating in the market include Agilent Technologies, Inc., Beijing Genomics Institute (BGI) Genomics Co., Ltd, Bionano Genomics, Inc., F. Hoffmann-La Roche Ltd., Illumina, Inc., Longas Technologies Pty Ltd, Novogene Co., Ltd., Oxford Nanopore Technologies, Inc., Pacific Biosciences of California, Inc., PerkinElmer Inc., QIAGEN N.V., Quantapore, Inc., and Thermo Fisher Scientific Inc.

Similar Product

You may also like

Global Whole Genome and Exome Sequencing Market
Published Year: 2020

Global Whole Genome and Exome Sequencing Market: Focus on Product, Workflow, Application, End User,

The global market for whole genome and exome sequencing is predicted to grow at a CAGR of...

Global Next-Generation Sequencing Market
Published Year: 2019

Global Next-Generation Sequencing Market: Focus on Products and Services, Applications, Technology,

In 2018, the global next-generation sequencing market was valued at $4.93 billion and is...

Global Cancer Immunotherapy Market
Published Year: 2019

Global Cancer Immunotherapy Market: Focus on Pharmaceutical Products, Therapeutic Indication, Compet

The global cancer immunotherapy market was valued at $39.86 billion in 2017 and is anticipated...